Skip to main content

Advertisement

Table 1 Baseline charateristics of participants (n = 37)

From: Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial

Characteristic Mean ± SD (or N/%)
Age (years) 61.2 ± 6.7
Male sex (n/%) 15 (40.5%)
Duration of diabetes (years) 10 ± 6
Hypertension 32 (86.5%)
Dyslipidemia 14 (37.8%)
Current smoker 13 (35.1%)
BMI (kg/m2) 26.2 ± 2.9
Waist circumference (cm) 92.5 ± 8.0
Systolic blood pressure (mmHg) 131.9 ± 11.8
Diastolic blood pressure (mmHg) 79.2 ± 11.4
Fasting glucose (mg/dL) 133.4 ± 27.1
HbA1c (%)* 7.1 ± 1.1
Fasting insulin (μIU/mL)* 11.6 ± 1.6
HOMA-IR* 3.8 ± 1.6
QUICKI 0.32 ± 0.02
Total cholesterol (mg/dL) 155.2 ± 25.2
Triglyceride (mg/dL)* 131.1 ± 1.7
HDL-C (mg/dL) 46.2 ± 9.9
LDL-C (mg/dL) 91.6 ± 21.2
hsCRP (mg/L)* 1.07 ± 2.65
Mean baPWV (cm/sec) 1591.4 ± 192.6
Adiponectin (ng/mL)* 8.86 ± 1.87
IL-6 (pg/mL)* 3.99 ± 2.94
TNF-α (ng/dL)* 6.36 ± 1.27
MCP-1 (ng/dL)* 590.2 ± 1.63
sVCAM-1 (ng/dL) 1224.4 ± 267.6
sICAM-1 (ng/dL)* 169.7 ± 1.29
  1. HOMA-IR, homeostasis model assessment of insulin resistance, QUICKI quantitative insulin sensitivity check index, hsCRP high sensitivity C-reactive protein, baPWV brachial-ankle pulse wave velocity, IL-6 interleukin-6, TNF-α tumor necrosis factor-alpha, MCP-1 monocyte chemotactic protein-1, sVCAM-1 soluble vascular cellular adhesion molecule-1, sICAM-1 soluble intercellular adhesion molecule-1.
  2. Data are presented as the mean ± SD. *Geometric mean ± SD.